Grupo para la caracterización molecular de las neoplasias hematológicas
Leeds and York Partnership NHS Foundation Trust
Leeds, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von Leeds and York Partnership NHS Foundation Trust (1)
2018
-
Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: A GIMEMA, ERIC and UK CLL FORUM study
Haematologica, Vol. 103, Núm. 7, pp. 1209-1217